Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...

Vikrant Shrotriya, Corporate Vice President & Managing Director of Novo Nordisk India, during a session on India Today Conclave 2025, said that many celebrities may not want to admit to taking Ozempic ...

Vikrant Shrotriya, Novo Nordisk India's Managing Director, addressed concerns over the side-effects of Ozempic. He said that the weight-loss drug has been through a thorough evaluation process.

People on Ozempic and other GLP-1 agonist drugs commonly report they no longer have constant, incessant thoughts about food. This is how the drugs work.

Arkansas Blue Cross and Blue Shield recently filed a loss totaling $226 million with the Arkansas Insurance Department for ...

Preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is not associated with short-term postoperative ...

GLP-1 medications have become a popular weight loss method, but what do Americans really think about them? To find out, we surveyed U.S. adults on their experiences.

A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide—also known as ...

LifeMD (LFMD) announced it is integrating with LillyDirect pharmacy provider, Gifthealth, to offer streamlined access of single-dose vials of ...

A large population-based cohort study reports that using GLP-1 RAs significantly reduces the risk for cardiovascular events ...

GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study sugges ...

Patients with T2D who undergo kidney transplants are less likely to experience organ failure and mortality if they receive ...